Canine UTIs: Diagnostic Rules and Antibiotic Stewardship

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-02

Key Takeaways

• Definitive diagnosis of canine urinary tract infection (UTI) necessitates urinalysis and urine culture, ideally via cystocentesis, to confirm bacterial presence and guide targeted antibiotic therapy, rather than relying solely on clinical signs.
• Subclinical bacteriuria (SBU), characterized by bacteria in urine without clinical signs, should not be treated with antibiotics as it offers no clinical benefit and actively contributes to antimicrobial resistance.
• Empirical antibiotic therapy for UTIs should be reserved for severe clinical presentations and guided by local resistance data, prioritizing narrow-spectrum agents like amoxicillin or trimethoprim-sulfonamide if susceptibility is confirmed.
• Atypical and multidrug-resistant pathogens, such as Escherichia marmotae, Pluralibacter gergoviae, and E. coli ST131, are increasingly identified, underscoring the importance of molecular diagnostics for accurate identification and effective treatment selection.
• Management of recurrent UTIs requires thorough investigation for underlying causes, including urolithiasis (e.g., struvite stones amenable to medical dissolution) and endocrine diseases, alongside appropriate antimicrobial therapy.
• Cranberry supplementation has demonstrated no proven efficacy for UTI treatment or prevention in dogs, and its use is not supported by current evidence, highlighting the need for evidence-based therapeutic approaches.

A urinary tract infection (UTI) in a dog is a bacterial infection affecting any part of the urinary system, most commonly the bladder (cystitis). For pet owners, the first sign is often frequent straining to urinate, accidents in the house, or blood in the urine. If you observe these signs, contact your veterinarian promptly. Do not attempt home treatment with over-the-counter remedies, as they are ineffective and can delay proper care. This article provides a comprehensive, evidence-based overview of how veterinarians diagnose UTIs and why antibiotic stewardship is critical for your dog’s health and public health.

At a Glance: Canine UTI Management

Understanding the Urinary Tract and Infection

The urinary tract consists of the kidneys, ureters, bladder, and urethra. The upper tract (kidneys and ureters) and lower tract (bladder and urethra) can become infected. Most UTIs in dogs are ascending infections, meaning bacteria enter through the urethra and multiply in the bladder.

The most common pathogen is Escherichia coli (E. coli), but other bacteria like Proteus spp., Staphylococcus spp., and Klebsiella pneumoniae are also frequently isolated [<a href="#ref-1">1</a>][<a href="#ref-8">8</a>]. In a meta-analysis of studies published up to October 2024, the pooled prevalence of UTIs in dogs with lower urinary tract disease was 44.6%, with E. coli being the most common uropathogen [<a href="#ref-1">1</a>].

The Rise of Atypical and Resistant Pathogens

Historically, UTIs were attributed to well-known bacteria. However, advanced diagnostic techniques are revealing that the spectrum of uropathogens is broader than previously thought.

• Escherichia marmotae: A case report documented a UTI in a dog caused by E. marmotae, a member of the Escherichia cryptic clades. This bacterium is phenotypically similar to E. coli and was initially misidentified using standard techniques. Whole-genome sequencing (WGS) was required for definitive identification. The isolate was resistant to cefalexin, a common empirical choice, highlighting the risk of treatment failure with atypical pathogens [<a href="#ref-5">5</a>].
• Pluralibacter gergoviae: Another case report described a UTI in a dog in Peru caused by Pluralibacter gergoviae, an unusual Enterobacterales species. It was initially misidentified as Klebsiella pneumoniae. WGS confirmed the species and revealed it was susceptible to most antibiotics except penicillin. This case underscores the role of molecular diagnostics in detecting atypical uropathogens and the importance of One Health surveillance [<a href="#ref-9">9</a>].
• E. coli ST131: This globally disseminated multidrug-resistant clone is a significant public health threat. A study of 400 E. coli isolates from dogs and cats with UTIs in Taiwan found that 13.5% of phylogroup B2 isolates were ST131. These isolates were universally resistant to amoxicillin and ampicillin, and some produced extended-spectrum β-lactamases (ESBLs) [<a href="#ref-10">10</a>].

Diagnostic Rules: From Clinical Signs to Definitive Diagnosis

A definitive diagnosis of a UTI requires more than just clinical signs. It requires a systematic approach that includes a thorough history, physical examination, urinalysis, and ideally, a urine culture.

Clinical Signs and Owner Observations

Owners may report a variety of signs, including:

• Stranguria (straining to urinate)
• Pollakiuria (frequent urination of small amounts)
• Hematuria (blood in the urine)
• Inappropriate urination (accidents in the house)
• Foul-smelling or cloudy urine
• Lethargy, anorexia, or fever (more common with pyelonephritis)

These signs are not specific to UTIs. They can also be caused by urolithiasis (bladder stones), neoplasia (cancer), or anatomical abnormalities. Therefore, diagnostic testing is essential.

The Importance of Urinalysis

Urinalysis is the first-line diagnostic test. It provides immediate information about urine concentration, pH, and the presence of blood, protein, and inflammatory cells.

• Pyuria: The presence of white blood cells (WBCs) in the urine suggests inflammation. However, pyuria is not synonymous with infection. A study found that subclinical pyuria (pyuria without signs of lower urinary tract disease) occurs in 2.88% of dogs [<a href="#ref-3">3</a>].
• Bacteriuria: The presence of bacteria in the urine sediment can support a diagnosis of UTI, but it can also be a contaminant or represent subclinical bacteriuria (SBU).

Subclinical Bacteriuria (SBU)

SBU is defined as the presence of significant bacteriuria in a dog that lacks clinical signs attributable to a lower UTI [<a href="#ref-2">2</a>]. It is a common finding. A prospective cross-sectional study found the prevalence of SBU to be 9.81% in dogs without signs of lower urinary tract disease [<a href="#ref-3">3</a>].

The critical rule for SBU is: do not treat it with antibiotics. Treating SBU does not provide clinical benefit and contributes to antimicrobial resistance. This is a cornerstone of antibiotic stewardship.

Urine Culture: The Gold Standard

A urine culture is the gold standard for diagnosing a UTI. It confirms the presence of bacteria and allows for antimicrobial susceptibility testing (AST) to guide antibiotic selection.

How to collect urine for culture:

• Cystocentesis: This is the preferred method. Urine is collected directly from the bladder using a needle and syringe. This avoids contamination from the distal urethra and genital tract.
• Catheterization: This can be used, but carries a higher risk of contamination.
• Free catch: This is the least desirable method for culture due to a high risk of contamination.

When is a culture indicated?

• For any dog with suspected UTI, especially if empirical therapy is being considered.
• For dogs with recurrent UTIs.
• For dogs with complicated UTIs (e.g., those with uroliths, diabetes, or anatomical abnormalities).
• For monitoring treatment efficacy in cases of pyelonephritis.

Point-of-Care (POC) Testing and AST

Traditional culture and AST can take 48-72 hours. Point-of-care (POC) systems are being developed to provide rapid results. The Sysmex PA-100 AST System is one such device. A study evaluated its suitability for veterinary samples and found a sensitivity of 87.1% and specificity of 87.7% for detecting UTIs in dogs. The negative predictive value was high (94.7%), meaning a negative result is reliable. However, the positive predictive value was lower (73.0%), indicating that a positive result should be confirmed with culture [<a href="#ref-11">11</a>]. These POC systems hold promise for faster, targeted therapy, but they are not yet a complete replacement for traditional culture.

Advanced Diagnostics: Molecular Methods

As noted earlier, standard biochemical methods can misidentify atypical pathogens. Whole-genome sequencing (WGS) is a powerful tool for definitive species identification and for detecting antimicrobial resistance genes. This is particularly important for epidemiological surveillance and for understanding the emergence of resistant clones like E. coli ST131 [<a href="#ref-5">5</a>][<a href="#ref-9">9</a>][<a href="#ref-10">10</a>].

Antibiotic Stewardship: A Core Principle

Antibiotic stewardship is the set of coordinated strategies to improve the use of antibiotics by promoting the selection of the right drug, at the right dose, at the right time, and for the right duration. This is critical to slow the emergence of antimicrobial resistance (AMR).

The Threat of Antimicrobial Resistance

Antimicrobial resistance is a global health concern. Companion animals can serve as reservoirs for multidrug-resistant (MDR) bacteria that can be transmitted to humans. A study of urinary bacterial isolates from hospitalized dogs in South Korea found that 73.91% were MDR according to CLSI guidelines. Notably, one E. coli strain possessed the *bla*NDM-1 gene, which encodes a carbapenemase, an enzyme that inactivates carbapenems, a class of last-resort antibiotics [<a href="#ref-8">8</a>].

The genetic links between human and dog isolates are increasingly clear. Genomic analysis has revealed close genetic similarity between ESBL-producing E. coli from humans and dogs, suggesting potential for inter-species transmission [<a href="#ref-12">12</a>]. Similarly, a study found significant phylogenetic relatedness between antibiotic-resistant E. coli from raw meat and raw dog food and those causing human infections, although the direction of transmission is complex [<a href="#ref-13">13</a>].

Principles of Antibiotic Selection

When a UTI is diagnosed and antibiotic therapy is warranted, the choice of drug should be guided by culture and susceptibility results whenever possible.

• Empirical Therapy: If empirical therapy is necessary (e.g., severe clinical signs), the veterinarian should select a drug with a narrow spectrum of activity and a low propensity for resistance. Amoxicillin is often a reasonable first choice for uncomplicated UTIs, provided local resistance rates are low.
• Trimethoprim-Sulfonamide: This combination is effective, but sulfonamides can cause severe adverse effects in dogs, including keratoconjunctivitis sicca (dry eye) and potentially fatal blood dyscrasias. A study explored the use of trimethoprim alone for canine UTIs. The study found that after a single oral dose of 5 mg/kg trimethoprim, urine concentrations at 6, 8, 12, and 24 hours post-administration all exceeded 8 mcg/mL, the susceptible breakpoint for Enterobacterales UTIs in human patients. This suggests that trimethoprim monotherapy might be a viable option, but specific breakpoints and pharmacodynamics in dogs have not yet been established [<a href="#ref-4">4</a>].
• Ceftiofur: This is a third-generation cephalosporin used in veterinary medicine. A study established veterinary-specific breakpoints for ceftiofur against canine E. coli. The wild-type cutoff (COWT) was determined as 1 μg/mL, the pharmacokinetic/pharmacodynamic cutoff (COPD) as 0.25 μg/mL, and the clinical cutoff (COCL) as 2 μg/mL. These breakpoints are essential for interpreting susceptibility testing results and guiding therapy [<a href="#ref-14">14</a>].

The Problem of Treating Subclinical Bacteriuria

Treating SBU is a common error that contributes to AMR. A study on the local immune response in dogs with SBU found that urinary interleukin-8 (uIL-8) levels were higher in dogs with bacteriuria and increased with disease severity. However, there was significant overlap between dogs with SBU and those with pyelonephritis, making it impossible to use uIL-8 alone to distinguish between them. Interestingly, urinary myeloperoxidase (uMPO) concentrations differed between dogs with pyelonephritis and those with SBU without overlapping values, suggesting it could be a useful biomarker, but this is not yet a clinical tool [<a href="#ref-2">2</a>].

The decision to treat should be based on clinical signs, not just the presence of bacteria. If a dog has no clinical signs of a UTI, antibiotics are not indicated.

Management of Complicated and Recurrent UTIs

Recurrent UTIs are defined as two or more infections in six months or three or more in one year. These cases require a thorough investigation to identify underlying predisposing factors.

Identifying and Managing Underlying Causes

• Urolithiasis (Bladder Stones): Struvite stones are often associated with bacterial infections. Medical dissolution with a therapeutic urinary diet and antimicrobial therapy can be effective. A retrospective study of 13 dogs with suspected struvite uroliths found that complete dissolution occurred in 9 dogs (69%) when fed a therapeutic multipurpose urinary food and treated with antimicrobials. The mean time to dissolution was 71 ± 52 days [<a href="#ref-6">6</a>].
• Endocrine Disease: Conditions like diabetes mellitus and hyperthyroidism (in cats) are associated with an increased risk of bacteriuria [<a href="#ref-3">3</a>].
• Anatomical Abnormalities: Conditions like ectopic ureters or vaginal strictures can predispose to UTIs.
• Immunosuppression: Diseases or medications that suppress the immune system can increase susceptibility.

When to Consider Advanced Diagnostics

For recurrent or atypical infections, molecular diagnostics like WGS can be invaluable. They can identify unusual pathogens like E. marmotae or P. gergoviae that might be misidentified by standard methods, leading to inappropriate treatment [<a href="#ref-5">5</a>][<a href="#ref-9">9</a>]. They can also detect specific resistance genes, such as *bla*CTX-M or *bla*NDM-1, which have significant implications for treatment choices and public health [<a href="#ref-10">10</a>][<a href="#ref-8">8</a>][<a href="#ref-12">12</a>].

Evidence on Alternative and Adjunct Therapies

Pet owners often seek alternative or adjunctive treatments for UTIs.

Cranberry Supplementation

Cranberry is a popular home remedy. A systematic review evaluated the effectiveness of cranberry supplementation for the prevention and treatment of bacterial cystitis and subclinical bacteriuria in dogs and cats. The review identified only three studies involving a total of 122 animals. No studies reported statistically significant or numerical impacts of treatment. The certainty of evidence was low to very low. The authors concluded that the small number of studies and low certainty of evidence preclude a confident assessment of the role of cranberry for UTIs in dogs and cats [<a href="#ref-7">7</a>].

Immunomodulatory Therapy

In specific cases, such as eosinophilic cystitis (an inflammatory condition of the bladder), immunomodulatory drugs may be used. A case report described a paraplegic dog with eosinophilic cystitis that responded well to cyclosporine treatment, with significant clinical improvement and no adverse effects [<a href="#ref-15">15</a>]. This is a niche therapy for a specific non-infectious condition, not a general treatment for UTIs.

Prevention and Prognosis

Prevention Strategies

Preventing UTIs focuses on reducing risk factors and promoting overall urinary health.

• Hydration: Ensure your dog has access to fresh, clean water at all times.
• Frequent Urination: Provide opportunities for your dog to urinate frequently, especially if they are prone to UTIs.
• Address Underlying Conditions: Manage endocrine diseases like diabetes mellitus effectively.
• Avoid Unnecessary Antibiotics: Do not ask your veterinarian for antibiotics unless they are clinically indicated. This is the most important preventive measure for AMR.

Prognosis

The prognosis for uncomplicated UTIs in dogs is generally excellent with appropriate antibiotic therapy. However, the prognosis is more guarded for complicated UTIs, especially those associated with MDR bacteria, uroliths, or underlying systemic diseases. The emergence of carbapenem-resistant organisms like the *bla*NDM-1-positive E. coli is a serious concern for treatment outcomes [<a href="#ref-8">8</a>].

Limitations and When to Contact a Veterinarian

This article provides general information and is not a substitute for professional veterinary advice. Every dog is an individual, and the diagnostic and therapeutic approach must be tailored to the specific patient.

Breed-level information cannot predict individual outcomes. While some breeds may have a higher prevalence of certain conditions, this does not determine what will happen in your dog. Always consult your veterinarian for a diagnosis and treatment plan.

When to contact a veterinarian immediately:

• If your dog is unable to urinate (this is a life-threatening emergency).
• If your dog is vomiting, lethargic, or has a fever.
• If you see blood in the urine.
• If your dog's condition does not improve within 48 hours of starting treatment.

Frequently Asked Questions

1. What are the most common signs of a urinary tract infection in a dog?

The most common signs include straining to urinate, frequent urination of small amounts, blood in the urine (hematuria), and accidents in the house. Some dogs may also have foul-smelling or cloudy urine.

2. How does a veterinarian diagnose a UTI in a dog?

A veterinarian diagnoses a UTI based on a combination of clinical signs, a physical examination, and urinalysis. A urine culture is the gold standard for confirming the infection and identifying the specific bacteria to guide antibiotic selection [<a href="#ref-1">1</a>].

3. What is subclinical bacteriuria (SBU) and should it be treated?

Subclinical bacteriuria (SBU) is the presence of bacteria in the urine without any clinical signs of a urinary tract infection [<a href="#ref-2">2</a>]. It should not be treated with antibiotics, as treatment provides no clinical benefit and contributes to antimicrobial resistance [<a href="#ref-3">3</a>].

4. Why is antibiotic stewardship important for treating UTIs in dogs?

Antibiotic stewardship is crucial to slow the emergence of antimicrobial resistance (AMR). Multidrug-resistant bacteria in dogs can be a public health risk, as they can be transmitted to humans [<a href="#ref-8">8</a>]. Using antibiotics only when necessary and choosing the right drug are key principles.

5. Can cranberry supplements cure or prevent UTIs in dogs?

No, current evidence does not support the use of cranberry supplements for the prevention or treatment of UTIs in dogs. A systematic review found no significant impact of cranberry supplementation, and the certainty of evidence was low to very low [<a href="#ref-7">7</a>].

6. What should I do if my dog has recurrent urinary tract infections?

If your dog has recurrent UTIs (two or more in six months), your veterinarian should investigate underlying causes such as bladder stones, anatomical abnormalities, or endocrine diseases like diabetes mellitus [<a href="#ref-3">3</a>][<a href="#ref-6">6</a>]. A urine culture and advanced diagnostics may be necessary.

7. Are urinary tract infections in dogs contagious to humans?

Some bacteria that cause UTIs in dogs, such as ESBL-producing E. coli, are zoonotic and can potentially be transmitted between dogs and humans. Genomic studies have shown close genetic similarity between human and dog isolates, suggesting potential for inter-species transmission [<a href="#ref-12">12</a>].

8. What is the prognosis for a dog with a urinary tract infection?

The prognosis for an uncomplicated UTI is generally excellent with appropriate antibiotic therapy. The prognosis is more guarded for complicated UTIs, especially those caused by multidrug-resistant bacteria or associated with underlying diseases like urolithiasis [<a href="#ref-8">8</a>][<a href="#ref-6">6</a>].

Sources

Related Clinical & Scientific Guides

• Urethral Prolapse in Bulldogs: Diagnosis, Treatment and Prevention
• Fanconi Syndrome in Basenjis: Genetic Testing and Urine Glucose Management
• Renal Amyloidosis in Shar-Peis: Symptoms, Diagnosis and Colchicine Dosing